Age-related increases in ozone-induced injury and altered pulmonary mechanics in mice with progressive lung inflammation

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 305, Issue 8, 2013, Pages

  Groves, Angela M ^a   Gow, Andrew J ^a   Massa, Christopher B ^a   Hall, LeRoy ^b   Laskin, Jeffrey D ^c   Laskin, Debra L ^a  

^a RUTGERS UNIVERSITY   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Aging; Emphysema; Macrophages; Ozone; Surfactant protein D

Indexed keywords

CHOLESTEROL; GALECTIN 3; HEME OXYGENASE; HEMOGLOBIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MANNOSE RECEPTOR; OZONE; REACTIVE NITROGEN SPECIES;

AGE; ANIMAL EXPERIMENT; ARTICLE; CELL HYPERPLASIA; CELL INFILTRATION; CYTOPLASM; DISEASE ASSOCIATION; EPITHELIUM HYPERPLASIA; FIBRIN DEPOSITION; GENOTYPE; HISTOLOGY; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS WALL; LUNG COMPLIANCE; LUNG INJURY; LUNG LAVAGE; LUNG MECHANICS; LUNG STRUCTURE; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGING; EMPHYSEMA; MACROPHAGES; OZONE; SURFACTANT PROTEIN D;

AGING; ANIMALS; LUNG INJURY; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; MICE; MICE, KNOCKOUT; OXIDANTS, PHOTOCHEMICAL; OZONE; PNEUMONIA; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RESPIRATORY MECHANICS; TIME FACTORS;

EID: 84885656135     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00027.2013     Document Type: Article

References (53)

1. Al-Hegelan M, Tighe RM, Castillo C, Hollingsworth JW. Ambient ozone and pulmonary innate immunity. Immunol Res 49: 173-191, 2011.
2. Betsuyaku T, Kuroki Y, Nagai K, Nasuhara Y, Nishimura M. Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid. Eur Respir J 24: 964-970, 2004.
3. Botas C, Poulain F, Akiyama J, Brown C, Allen L, Goerke J, Clements J, Carlson E, Gillespie AM, Epstein C, Hawgood S. Altered surfactant homeostasis and alveolar type 2 cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci USA 95: 11869-11874, 1998.
4. Brubaker AL, Palmer JL, Kovacs EJ. Age-related dysregulation of inflammation and innate immunity: lessons learned from rodent models. Aging Dis 2: 346-360, 2011.
5. Chen LC, Pace JL, Russell SW, Morrison DC. Altered regulation of inducible nitric oxide synthase expression in macrophages from senescent mice. Infect Immun 64: 4288-4298, 1996.
6. Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, Carter C, Yu BP, Leeuwenburgh C. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev 8: 18-30, 2009.
7. Ciencewicki J, Trivedi S, Kleeberger SR. Oxidants and the pathogenesis of lung diseases. J Allergy Clin Immunol 122: 456-468, 2008.
8. Collins RA, Ikegami M, Korfhagen TR, Whitsett JA, Sly PD. In vivo measurements of changes in respiratory mechanics with age in mice deficient in surfactant protein D. Pediatr Res 53: 463-467, 2003.
9. Cooney TP, Thurlbeck WM. The radial alveolar count method of Emery and Mithal: a reappraisal 1-postnatal lung growth. Thorax 37: 572-579, 1982.
10. Crouch E, Wright JR. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 63: 521-554, 2001.
11. Desqueyroux H, Pujet JC, Prosper M, Le Moullec Y, Momas I. Effects of air pollution on adults with chronic obstructive pulmonary disease. Arch Environ Health 57: 554-560, 2002.
12. Fakhrzadeh L, Laskin JD, Laskin DL. Deficiency in inducible nitric oxide synthase protects mice from ozone-induced lung inflammation and tissue injury. Am J Respir Cell Mol Biol 26: 413-419, 2002.
13. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann NY Acad Sci 908: 244-254, 2000.
14. Fredenburgh LE, Perrella MA, Mitsialis SA. The role of heme oxy-genase-1 in pulmonary disease. Am J Respir Cell Mol Biol 36: 158-165, 2007.
15. Gardai SJ, Xiao YQ, Dickinson M, Nick JA, Voelker DR, Greene KE, Henson PM. By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115: 13-23, 2003.
16. Glasser SW, Korfhagen TR, Wert SE, Bruno MD, McWilliams KM, Vorbroker DK, Whitsett JA. Genetic element from human surfactant protein SP-C gene confers bronchiolar-alveolar cell specificity in trans-genic mice. Am J Physiol Lung Cell Mol Physiol 261: L349-L356, 1991.
17. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 32: 593-604, 2010.
18. Groves AM, Gow AJ, Massa CB, Laskin JD, Laskin DL. Prolonged injury and altered lung function after ozone inhalation in mice with chronic lung inflammation. Am J Respir Cell Mol Biol 47: 776-783, 2012.
19. Guo CJ, Atochina-Vasserman EN, Abramova E, Foley JP, Zaman A, Crouch E, Beers MF, Savani RC, Gow AJ. S-nitrosylation of surfactant protein-D controls inflammatory function. PLoS Biol 6: e266, 2008.
20. Haczku A. Protective role of the lung collectins surfactant protein A and surfactant protein D in airway inflammation. J Allergy Clin Immunol 122: 861-879, 2008.
21. Haines DD, Lekli I, Teissier P, Bak I, Tosaki A. Role of haeme oxygenase-1 in resolution of oxidative stress-related pathologies: focus on cardiovascular, lung, neurological and kidney disorders. Acta Physiol (Oxf) 204: 487-501, 2012.
22. Hakansson HF, Smailagic A, Brunmark C, Miller-Larsson A, Lal H. Altered lung function relates to inflammation in an acute LPS mouse model. Pulm Pharmacol Ther 25: 399-406, 2012.
23. Herzog EL, Brody AR, Colby TV, Mason R, Williams MC. Knowns and unknowns of the alveolus. Proc Am Thorac Soc 5: 778-782, 2008.
24. Hodge S, Hodge G, Scicchitano R, Reynolds PN, Holmes M. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol 81: 289-296, 2003.
25. Ishii T, Hagiwara K, Kamio K, Ikeda S, Arai T, Mieno MN, Kuma-saka T, Muramatsu M, Sawabe M, Gemma A, Kida K. Involvement of surfactant protein D in emphysema revealed by genetic association study. Eur J Hum Genet 20: 230-235, 2012.
26. Ito S, Bartolak-Suki E, Shipley JM, Parameswaran H, Majumdar A, Suki B. Early emphysema in the tight skin and pallid mice: roles of microfibril-associated glycoproteins, collagen, and mechanical forces. Am J Respir Cell Mol Biol 34: 688-694, 2006.
27. Ito S, Ingenito EP, Brewer KK, Black LD, Parameswaran H, Lutchen KR, Suki B. Mechanics, nonlinearity, and failure strength of lung tissue in a mouse model of emphysema: possible role of collagen remodeling. J Appl Physiol 98: 503-511, 2005.
28. Janssens JP. Aging of the respiratory system: impact on pulmonary function tests and adaptation to exertion. Clin Chest Med 26: 469-484, vi-vii, 2005.
29. Khan MA, Ellis R, Inman MD, Bates JH, Sanderson MJ, Janssen LJ. Influence of airway wall stiffness and parenchymal tethering on the dynamics of bronchoconstriction. Am J Physiol Lung Cell Mol Physiol 299: L98-L108, 2010.
30. Kohut ML, Senchina DS, Madden KS, Martin AE, Felten DL, Moyni-han JA. Age effects on macrophage function vary by tissue site, nature of stimulant, and exercise behavior. Exp Gerontol 39: 1347-1360, 2004.
31. Kovacs EJ, Palmer JL, Fortin CF, Fulop T Jr, Goldstein DR, Linton PJ. Aging and innate immunity in the mouse: impact of intrinsic and extrinsic factors. Trends Immunol 30: 319-324, 2009.
32. Laskin DL, Sunil VR, Gardner CR, Laskin JD. Macrophages and tissue injury: agents of defense or destruction? Annu Rev Pharmacol Toxicol 51: 267-288, 2011.
33. MacNee W. Accelerated lung aging: a novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD). Biochem Soc Trans 37: 819-823, 2009.
34. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 13: 453-461, 2008.
35. Mason RJ. Biology of alveolar type 2 cells. Respirology 11 Suppl: S12-S15, 2006.
36. Meyer KC, Rosenthal NS, Soergel P, Peterson K. Neutrophils and low-grade inflammation in the seemingly normal aging human lung. Mech Ageing Dev 104: 169-181, 1998.
37. More JM, Voelker DR, Silveira LJ, Edwards MG, Chan ED, Bowler RP. Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease. BMC Pulm Med 10: 53, 2010.
38. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969, 2008.
39. Park GY, Christman JW. Involvement of cyclooxygenase-2 and pros-taglandins in the molecular pathogenesis of inflammatory lung diseases. Am J Physiol Lung Cell Mol Physiol 290: L797-L805, 2006.
40. Prokhorova S, Patel N, Laskin DL. Regulation of alveolar macrophage and type 2 cell DNA synthesis: effects of ozone inhalation. Am J Physiol Lung Cell Mol Physiol 275: L1200-L1207, 1998.
41. Raes G, De Baetselier P, Noel W, Beschin A, Brombacher F, Hassan-zadeh GG. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J Leukoc Biol 71: 597-602, 2002.
42. Sarkar D, Fisher PB. Molecular mechanisms of aging-associated inflammation. Cancer Lett 236: 13-23, 2006.
43. Sharma G, Hanania NA, Shim YM. The aging immune system and its relationship to the development of chronic obstructive pulmonary disease. Proc Am Thorac Soc 6: 573-580, 2009.
44. Smallwood HS, Lopez-Ferrer D, Squier TC. Aging enhances the production of reactive oxygen species and bactericidal activity in peritoneal macrophages by upregulating classical activation pathways. Biochemistry 50: 9911-9922, 2011.
45. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176: 287-292, 1992.
46. van Hoek AJ, Andrews N, Waight PA, Stowe J, Gates P, George R, Miller E. The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England. J Infect 65: 17-24, 2012.
47. Weis N, Weigert A, von Knethen A, Brune B. Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. Mol Biol Cell 20: 1280-1288, 2009.
48. Wert SE, Yoshida M, LeVine AM, Ikegami M, Jones T, Ross GF, Fisher JH, Korfhagen TR, Whitsett JA. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci USA 97: 5972-5977, 2000.
49. West JB. Respiratory Physiology: The Essentials. Philadelphia, PA: Lippincott Williams & Wilkins, 2008.
50. Winkler C, Atochina-Vasserman EN, Holz O, Beers MF, Erpenbeck VJ, Krug N, Roepcke S, Lauer G, Elmlinger M, Hohlfeld JM. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD. Respir Res 12: 29, 2011.
51. Yoshida M, Whitsett JA. Alveolar macrophages and emphysema in surfactant protein-D-deficient mice. Respirology 11 Suppl: S37-S40, 2006.
52. Zanobetti A, Schwartz J. Ozone and survival in four cohorts with potentially predisposing diseases. Am J Respir Crit Care Med 184: 836-841, 2011.
53. Zhang X, Mosser DM. Macrophage activation by endogenous danger signals. J Pathol 214: 161-178, 2008.